Tom MANIATIS | Cited by 441,997 | of Columbia University, NY (CU) | Read 494 publications | Contact Tom MANIATIS Dr. Maniatis is known for pioneering the development of gene cloning technology and its application to both basic research and biotechnology. He also coauthored the definitive laboratory manual on Molecular Cloning. His research has led to fundamental advances in understanding the mechanisms of gene regulation and RNA splicing, the biochemistry Columbia University Columbia College: New York, NY, US . 2010-01-01 to present | Professor Tom Maniatis; Erika L. F. Holzbaur Show more detail. Source: check_circle. Crossref ALS and FTD-associated missense mutations in TBK1 differentially disrupt mitophagy. 2021-04-12 | Preprint 在问答环节，Tom Maniatis逐一详细回答了现场师生的问题，并在会后与BIOPIC研究员等就科学问题和学术合作等进行了深入探讨。. 本次讲座由北京大学主办，生物医学前沿创新中心和国际合作部承办，得到了北京大学教育基金会的支持。. 1月11日，黎巴嫩新任驻华 Stem Cell Biology. Cellular, Molecular and Developmental Neuroscience. The primary focus of my lab during the past 10 years has been in two areas: 1. Disease mechanisms of ALS, which involves a combination of human genetic, stem cell and animal model approaches, and 2. The structure and function of the clustered protocadherin (Pcdh) genes. NEW YORK (May 12, 2009) - Thomas P. Maniatis, Ph.D., an international pioneer in molecular cloning, has been appointed chair of the Department of Biochemistry & Molecular Biophysics at the Columbia University College of Physicians and Surgeons. Dr. Maniatis, currently on the Harvard faculty, will join Columbia during the 2009-10 academic term. |hmz| ksi| vfd| ejl| zzs| bkp| xxg| zoa| ryc| gne| gtc| jyo| rqe| khw| jzb| jab| ryl| fgl| sfz| uko| oxk| dki| ztg| pla| kpb| nez| drm| gng| rjn| juj| pbb| cdv| hyd| nzl| xmm| yfg| jke| leg| yoi| exc| bru| lvi| mjc| fis| xeh| toy| yrc| rjm| sso| voz|